SEVERE ASTHMA

This study tested whether weekly reminder messages help adults with severe asthma stay on track with home breathing tests. Thirty participants used a digital device to measure lung function at home for three months. Those who got reminders completed more tests than those who didn…

This study looked at 33 people with severe asthma who received tezepelumab before it was widely available in Spain. Researchers checked how well the drug controlled asthma symptoms and tracked side effects. The goal was to see how the drug works outside of a clinical trial settin…

This study looked at 291 adults with severe eosinophilic asthma who were starting benralizumab (Fasenra). Researchers tracked how well the drug controlled their asthma symptoms over time using patient questionnaires. The goal was to see if benralizumab improves asthma control in …

This study tested a new medicine called verekitug in 479 adults with severe asthma. The goal was to see if it could reduce asthma attacks and improve breathing compared to a placebo. Participants received either the drug or a dummy treatment, and researchers tracked flare-ups and…

This study tested an investigational drug called TQC2731 in 205 adults with severe asthma that is not well controlled by current treatments. Participants received either one of three doses of TQC2731 or a placebo as a shot every 4 weeks for 48 weeks. The main goal was to see if t…

This study looked at 201 adults with severe asthma across Egypt to find out how many use oral corticosteroids (steroid pills). The researchers also checked for different asthma types, like eosinophilic asthma, and how well patients' asthma was controlled. The goal was to better u…

This study looked back at the medical records of 352 adults with severe asthma who received tezepelumab in UK clinics. Researchers tracked asthma attacks, steroid use, and other outcomes for one year after starting treatment. The goal was to see how well the drug works in real-wo…

This study looked back at medical records of 74 adults with severe asthma in Portugal who received benralizumab, a biologic drug. Researchers wanted to understand patient characteristics, how the drug was used, and what happened after treatment started. The goal is to provide rea…

This study looked at 54 children with severe asthma to better understand the different types of the disease. Researchers examined immune cells, lung tissue, and microbes from the children's airways. The goal was to identify patterns that could lead to more personalized treatments…

This study took blood samples from 4 people with severe asthma or a related condition called ABPA and turned their cells into stem cells. The goal was to grow functional bronchial (airway) tissue in a lab dish to study how mucus plugs form. The research aimed to validate this lab…

This study reviewed medical records of 197 adults in Israel with severe asthma who started taking benralizumab between 2019 and 2024. Researchers looked at how many asthma attacks patients had before and during treatment. The goal was to understand real-world benefits and patient…